Certified by Founder Lodge
CancerIQ
United States - Chicago, Illinois
START UP
1 Disclosed Funding Rounds $14,000,000
0 Participating Investments
-
Founded date
2013
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
About Us
CancerIQ helps providers use genetic information to predict, pre-empt, and prevent disease - starting with cancer. By making is easier to identify patients at risk, offer a genetic
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 04 ,2022 | Series B | $14,000,000 |
Amgen
McKesson Ventures
HealthX Ventures
Patchwork Health
Abridge
Salvo Health
CareBridge
Health Note
Pryzm | $2,000,000 | (Aug 29, 2024)
Ancilia Biosciences | $4,200,000 | (Aug 29, 2024)
Melodi Health | $10,750,000 | (Aug 29, 2024)
Parry Labs | $80,000,000 | (Aug 29, 2024)
Agency | $2,600,000 | (Aug 29, 2024)
